Oulai (Eltrombopag) 25mg Tablets | China Generic TPO-R Agonist | GLT

Generic Information: Oulai (China)

Generic name: eltrombopag olamine. Brand: Oulai (欧莱). Manufacturer: Jiangsu Aosaikang Pharmaceutical Co., Ltd. Origin: China-Mainland. Strength: 25 mg tablets, 14 tablets per pack. Class: oral thrombopoietin receptor agonist (TPO-RA).

Jiangsu Aosaikang is among the four manufacturers that received NMPA approval for eltrombopag olamine tablets on the same date in early 2024, marking the arrival of China's first domestic generics for this therapy.

What Is Oulai Used For?

Oulai raises platelet counts in adults and children aged 6 years and over with chronic immune thrombocytopenia (ITP) who have not responded adequately to corticosteroids or immunoglobulins. It is also used in severe aplastic anemia (SAA) where immunosuppressive therapy has been insufficient.

How Does Oulai Work?

Eltrombopag stimulates the thrombopoietin receptor (c-Mpl) on megakaryocytes, promoting their maturation and increasing platelet production. As an oral small molecule it avoids the injections needed by earlier TPO-RA therapies.

Indications

• Chronic ITP refractory to corticosteroids or IVIG
• Severe aplastic anemia refractory to immunosuppressive therapy

Dosage

Adults with ITP usually start at 50 mg once daily (two 25 mg tablets); East Asian patients may start lower. Titrate against platelet counts to maintain ≥50 × 10⁹/L, up to a maximum of 75 mg daily in ITP. Take on an empty stomach and away from dairy and mineral supplements.

Side Effects

Headache, nausea, diarrhoea and fatigue are most common. Monitor liver function and platelet counts regularly; rare but serious risks include hepatotoxicity and thrombosis.

Storage

Store at 20–25°C, dry, protected from light, out of reach of children.

Why Choose the GLT?

Oulai delivers originator-equivalent eltrombopag at a substantially lower cost than imported brands — a meaningful saving for long-term ITP therapy. GLT supplies this NMPA-approved Chinese generic with complete documentation and worldwide shipping.

How to Order

Contact GLT on WhatsApp +86 15234153837 or email [email protected] for a quotation on Oulai and other China-sourced eltrombopag generics.

FAQ

Is Oulai the same as Revolade? Oulai is a generic of eltrombopag, bioequivalent to the Novartis originator Revolade, manufactured by Jiangsu Aosaikang in China.

Is Oulai approved in China? Yes, it holds an NMPA approval as one of China's first domestic eltrombopag generics.

How is Oulai dosed? Typically 50 mg once daily for adults with ITP, adjusted by platelet count.

Can I buy Oulai from China? Yes, GLT exports this Chinese generic with full export documentation.